Search Results - "Toss, MS"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract P5-18-02: A quantitative centrosomal amplification score (CAS) predicts local recurrence in ductal carcinoma in situ

    Abstract P5-18-02: A quantitative centrosomal amplification score (CAS) predicts local recurrence in ductal carcinoma in situ by Mittal, K, Kaur, J, Wei, G, Toss, MS, Osan, RM, Janssen, EA, Søiland, H, Rakha, EA, Rida, PC, Aneja, R

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Abstract Background: About 60-80% of ductal carcinoma in situ (DCIS) cases are high-grade (HG) DCIS with an elevated risk of local recurrence (LR) even after a…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    PO-014 Targeting PARP1 in XRCC1 deficient sporadic invasive breast cancer or pre-invasive ductal carcinoma in situ for synthetic lethality and chemoprevention

    PO-014 Targeting PARP1 in XRCC1 deficient sporadic invasive breast cancer or pre-invasive ductal carcinoma in situ for synthetic lethality and chemoprevention by Ali, R, Al-kawaz, A, Toss, MS, Green, A, Miligy, IA, Mesquita, K Almeida, Seedhouse, C, Mirza, S, Rakha, E, Madhusudan, S

    Published in ESMO open (01-07-2018)
    “…IntroductionTargeting PARP1 for synthetic lethality is a novel strategy for BRCA germ-line mutated breast cancers. However, BRCA germ-line mutations are rare…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: